| Literature DB >> 29878125 |
Maria Chatzifrangkeskou1, David Yadin2, Thibaut Marais1, Solenne Chardonnet3, Mathilde Cohen-Tannoudji1, Nathalie Mougenot4, Alain Schmitt5, Silvia Crasto6,7, Elisa Di Pasquale6,7, Coline Macquart1, Yannick Tanguy1, Imen Jebeniani8, Michel Pucéat8, Blanca Morales Rodriguez1, Wolfgang H Goldmann9, Matteo Dal Ferro10, Maria-Grazia Biferi1, Petra Knaus2, Gisèle Bonne1, Howard J Worman11,12, Antoine Muchir1.
Abstract
Hyper-activation of extracellular signal-regulated kinase (ERK) 1/2 contributes to heart dysfunction in cardiomyopathy caused by mutations in the lamin A/C gene (LMNA cardiomyopathy). The mechanism of how this affects cardiac function is unknown. We show that active phosphorylated ERK1/2 directly binds to and catalyzes the phosphorylation of the actin depolymerizing factor cofilin-1 on Thr25. Cofilin-1 becomes active and disassembles actin filaments in a large array of cellular and animal models of LMNA cardiomyopathy. In vivo expression of cofilin-1, phosphorylated on Thr25 by endogenous ERK1/2 signaling, leads to alterations in left ventricular function and cardiac actin. These results demonstrate a novel role for cofilin-1 on actin dynamics in cardiac muscle and provide a rationale on how increased ERK1/2 signaling leads to LMNA cardiomyopathy.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29878125 PMCID: PMC6097156 DOI: 10.1093/hmg/ddy215
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150